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Introduction: Goal-Directed Fluid Therapy (GDFT) has been previously shown to decrease complications
and hospital length of stay in major colorectal surgery but the data are not speciﬁc to rectal surgery and
may be potentially outdated. This study investigated whether GDFT provides clinical beneﬁts in patients
undergoing major elective rectal surgery. Methods: There were 81 consecutive patients in this cohort
study. Twenty-seven patients were allotted to GDFT using the Oesophageal Doppler Monitor (ODM) and
received boluses of colloid ﬂuid based on corrected ﬂow time and stroke volume. These patients were
compared with a historical cohort of the previous 54 patients managed without the ODM. The primary
endpoint of the study was 30-day total complications which were deﬁned and graded. Secondary
endpoints included hospital length of stay (LOS) and ﬂuid volumes administered. Results: There were no
differences at baseline between the two groups. Patients in the treatment group received a higher
volume of colloid ﬂuids (1000 mL vs. 500 mL; p < 0.01) but there were no differences in overall ﬂuid
volumes administered intraoperatively (3000 mL vs. 3000 mL; p ¼ 0.41). A non-signiﬁcant trend
(p ¼ 0.06) suggested that patients allotted to GDFT had decreased ﬂuid requirement in the ﬁrst 24 h after
surgery. There were no differences in median total ﬂuid volumes (12700 mL vs. 10407 mL; p ¼ 0.95), total
complications (22 [81%] vs. 44 [81%]; p ¼ 1.00) or median hospital LOS (9 days vs. 10 days; p ¼ 0.92)
between the two groups. Conclusion: Intraoperative GDFT did not improve clinical outcomes following
major elective rectal surgery.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
In the setting of major colorectal surgery, intravenous ﬂuid is
administered based on either ﬁxed-volume regimens or in an
individualised manner based on markers of ﬂuid-responsiveness
using additional monitoring such as the Oesophageal Doppler
Monitor (ODM) [1e3]. The latter is known as Goal-directed ﬂuid
therapy (GDFT) and is being increasingly adopted into practice [4].
GDFT has been recommended for routine use in major abdominal).
by Elsevier Ltd. All rights reservedsurgery in the United Kingdom and has been adopted as ‘best
practice’ by the National Health Service [4]. It is also funded for use
by the Medicare and Medicaid systems in the USA [5,6]. It has been
shown to decrease total complications and hospital length of stay
with valid scientiﬁc reasoning to explain the beneﬁts of perioper-
ative ﬂuid optimisation [7,8].
Some of the published studies are speciﬁc to colorectal surgery
whilst others have been conducted in patients undergoing a variety
of major abdominal surgical procedures [9e11]. However, most of
the colorectal-speciﬁc studies have not made a distinction between
colon and rectal surgery even though these operations have been
shown to be physiologically distinct from one another [12]..
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metabolic burden of stoma creation. This may also inﬂuence post-
operative ﬂuid requirements [13]. Important shortcomings of the
evidence base governing goal-directed ﬂuid therapy in major
colorectal surgery have also been previously described and as a
result, further procedure-speciﬁc studies have been thought to be
necessary [13,14]. Thus, we conducted a study to examine the in-
ﬂuence of goal-directed ﬂuid therapy on clinical outcomes-with
total complications as the primary focus-after elective rectal
surgery.
2. Methods
2.1. Study design
Following regional and institutional ethical approval, written
informed consent was obtained from 27 consecutive patients un-
dergoing major elective rectal surgery at our institution. These
patients all received intraoperative GDFT as guided by ODM mea-
surements andwere compared to a historical cohort of the previous
consecutive 54 patients for a total of 81 consecutive patients.
Rectal surgery was deﬁned as any resection including a section
of bowel within 15 cm of the anal verge. Exclusion criteria for the
study were acute operations, multivisceral resections, patient
refusal, severe bleeding diathesis, severe oesophageal disease,
recent oesophageal surgery and moderate/severe aortic valve dis-
ease as assessed by transthoracic echocardiogram.
Baseline characteristics were noted. The primary outcome for
the study was 30-day total complications and these were graded
using the ClavieneDindo classiﬁcation and deﬁned based on pub-
lished criteria [15,16]. The secondary outcomes for the study were
day tomeet discharge criteria; hospital length of stay; administered
ﬂuid volumes in the preoperative; intraoperative and postoperative
period and total intravenous ﬂuid administered. The intraoperative
period was deﬁned as the time within which the patient was in the
operating theatre with the preoperative and postoperative period
being before and after respectively. Clinical outcomes for the
treatment group were noted prospectively and at the conclusion of
patient recruitment, all outcomes were veriﬁed by personnel
blinded to patient allocation on an intention-to-treat basis.
2.2. Preoperative management
Patients received preoperative carbohydrate loading and pa-
tients receiving bowel preparation received one litre of crystalloid
ﬂuid prior to surgery (Plasmalyte, Baxter Healthcare, NSW,
Australia). Use of bowel preparationwas at the surgeon's discretion.
2.3. Intraoperative management
All aspects of surgical technique were left up to the consultant
surgeon.
All patients received volatile general anaesthesia and thoracic
epidural analgesia was used, unless contraindicated, and activated
from the initiation of the case. A low dose vasopressor infusionwas
used with metaraminol as the most common pressor. Patients
received invasive blood pressuremonitoring at the discretion of the
anaesthetist. Eight milligrams of intravenous dexamethasone were
administered at induction [17,18].
All patients in the treatment group had continuous Oesophageal
Doppler monitoring (Cardio Q, Pharmaco Inc, Auckland, NZ) and
had a disposable oesophageal probe inserted for this purpose (DP-
12, Pharmaco Inc, Auckland, NZ). Monitoring was discontinued at
the end of the operation and the probe was removed prior to
extubation in the operating room. The ODMprobewas inserted andoperated by a trained research assistant who had no input into any
other aspects of perioperative care. All data were recorded over an
average of ten cycles [19]. Intraoperative ﬂuid administration was
in conjunction with the anaesthetist and was guided by a previ-
ously used protocol relying on obtainedmeasurements of corrected
ﬂow time and stroke volume as shown in Fig. 1 [9,10]. Weight-
based boluses of hydroxyethyl starch colloid (Voluven, Fresenius
Kabi, NSW, Australia) were administered as outlined in the proto-
col. Due to concern regarding renal toxicity, gelatin based colloids
(Gelofusine, Baxter Health, Auckland, NZ) were permitted if vol-
umes greater than two litres were required. Plasmalyte was used as
the intraoperative crystalloid. Blood products were used if the
haemoglobin was less than 80 g/L in an otherwise well patient or
less than 100 g/L in a patient with documented cardiac disease.
Patients in the control group were managed without the ODM and
their ﬂuid management was at the discretion of the anaesthetist
without a formal protocol specifying the use of colloid or
crystalloid.2.4. Postoperative care
The principles of enhanced recovery care were followed though
a formal protocol has not been established for rectal surgery within
our institution. Patients were allowed to eat solid food from the
evening of the operation. Oral ﬂuid intake was also encouraged as
well as early mobilisation. Caloric supplementation was also pro-
vided (Fortisip, Nutricia Inc, Auckland, New Zealand). Epidural
analgesia was continued till 72 h postoperatively and urinary
catheters were left in till this time. Simple oral analgesia was pro-
vided regularly with avoidance of opioid analgesia unless required
for break-through pain. Non-steroidal analgesia was used from
postoperative day two (20 mg Tenoxicam, Valeant Pharmaceuticals
Ltd, Auckland, New Zealand).
All intravenous ﬂuids were stopped upon the patient arriving at
the ward and oral intake of food; ﬂuids and supplements was
encouraged. The patient was then formally assessed by the ward
doctor to decide whether any intravenous ﬂuid was necessary.
Clinicians were required to see the patient and document their
ﬁndings and were not allowed to make decisions over the phone.
This judgement was based on patient observations, clinical exam-
ination and urine output. Examination ﬁndings consistent with
volume deﬁcit were required to prescribe intravenous ﬂuid (e.g.
decreased jugular venous pulse). Intravenous ﬂuid was adminis-
tered if patients were oliguric (deﬁned as less than 0.5 mL/kg/h
averaged over four hours) or had deranged physiological parame-
ters suggestive of volume deﬁcit (tachycardia (>90 bpm)), low
blood pressure (systolic blood pressure < 90 mmHg in the presence
of a functioning epidural; <100 mmHg without an epidural)
Intravenous ﬂuid was also administered for resuscitative purposes
in the event of complications, to compensate for losses such as in
high output stomae or for poor oral intake such as in paralytic ileus.2.5. Discharge criteria
The following criteria had to be satisﬁed for patients to be
eligible for discharge: Painmanaged by oral analgesia alone; able to
mobilise at least to and from the toilet; passage of ﬂatus either per
rectally or via stoma; able to tolerate solid foods; satisfactory
capability to manage stoma as determined by the stoma therapist;
normalising blood tests including C reactive protein; absence of
complications.
Fig. 1. Intraoperative ﬂuid administration protocol.
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Based on internal audit data, using a two-tailed Fisher's exact
test in a 1:2 ratio, with an alpha of 0.05 and power of 80%, 27 pa-
tients were needed in the treatment group to detect a 30% differ-
ence in the primary outcome. Total complications were chosen as
the primary outcome due to clinical signiﬁcance and the reasoning
that any improvement would lead to a consequent decrease in day
stay due to improvement in patient condition rather than service
efﬁciency. Due to the high complication rate in rectal surgery and
previous data showing a 72% decrease in total complications from
the use of GDFT, a 30% decrease in complications was considered
realistic and clinically signiﬁcant [7]. Data were analysed using theManneWhitney U Test and the two-tailed Fisher's exact test with a
p < 0.05 being considered statistically signiﬁcant. SPSS v13.0 (SPSS
Inc, Irv, CA) was used for all statistical analysis.
3. Results
All eligible patients consented to participate in the study and
thus 27 consecutive patients were recruited and comparedwith the
previous 54 patients over a period of time from May 2008 to May
2011. One patient in the treatment group became too unstable due
to intraoperative haemorrhage and the protocol was abandoned in
favour of a massive transfusion protocol as per hospital guidelines.
There were no other violations of the protocol. The patients were
Table 2
Perioperative ﬂuid amounts.
GDFT (n ¼ 27) Control (n ¼ 54) P
value
Preoperative
Crystalloid 1000 [0e1000] 875 [0e2220] 0.61
Colloid 0 0 1.00
Intraoperative
Crystalloid 2000 [300e4200] 3000 [1000e6000] <0.01
Colloid 1000 [0e2500] 500 [0e1500] <0.01
Total ﬂuid 3000 [1000e6500] 3000 [1500e6000] 0.41
Blood transfusiony 7 (26%) 6 (11%) 0.11z
Inotropey 22 (82%) 51 (94%) 0.11z
Postoperative day 0
Crystalloid 1000 [0e6500] 1025 [0e4200] 0.54
Colloid 0 [0e1000] 0 [0e1500] 0.74
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operated on all 81 patients with no signiﬁcant difference between
surgeons in the proportion of patients in each group that they
operated on.
Administered ﬂuid amounts are shown in Table 2. Patients in the
treatment arm received more colloid ﬂuids intraoperatively though
there was no difference in total ﬂuid volumes administered intra-
operatively. There were no other statistically signiﬁcant differences
between administered ﬂuid volumes in the perioperative period.
There was a non-signiﬁcant trend showing a decreased ﬂuid
requirement for the ﬁrst 24 h postoperatively in patients receiving
GDFT (p ¼ 0.06).
There were no differences in clinical outcomes between the two
groups as shown in Table 3.Postoperative day 1
Crystalloid 1450 [0e4630] 1780 [0e4250] 0.06
Colloid 0 [0e1250] 0 [0e1250] 0.89
Postoperative day 2
Crystalloid 500 [0e4920] 1000 [0e4550] 0.28
Colloid 0 [0e500] 0 [0e1500] 0.21
Postoperative day 3
Crystalloid 0 [0e5760] 295 [0e6600] 0.87
Colloid 0 [0e750] 0 [0e3000] 0.71
Total postoperative ﬂuid day 1
e3
3800 [0e15,816] 5500 [1000
e13,640]
0.37
Total postoperative ﬂuid 7840 [0e61,350] 6605 [1000
e38,160]
0.84
Total ﬂuid 12,700 [2600
e63,550]
10,407 [5000
e43,660]
0.95
Fluid amounts are shown in millilitres and expressed as medians [range].
yExpressed as number of patients receiving blood transfusion or inotropes. Man-
neWhitney U test used unless otherwise stated. zFisher's exact test.
Table 3
Clinical outcomes.
GDFT (n ¼ 27) Control (n ¼ 54) P value4. Discussion
This prospective study has demonstrated that intraoperative
GDFT did not improve clinical outcomes in patients undergoing
major elective rectal surgery. The administered ﬂuid volumes be-
tween the two groups were not signiﬁcantly different though pa-
tients allotted to GDFT received a higher proportion of colloid ﬂuids
intraoperatively. A non-signiﬁcant trend suggested that patients in
the treatment arm had decreased ﬂuid requirements for the ﬁrst
24 h after surgery.
The ﬁndings of this study are dissimilar to early published trials
and meta-analyses that have been the basis for policy decisions
[4,7,9]. This may be due to our study being different from the initial
studies exploring GDFT in several ways. Our study was conducted
in rectal surgery alone. Rectal surgery has been shown to be
physiologically distinct from colonic surgery as evidenced by pat-
terns of cytokine release [12]. Moreover, rectal surgery is more
likely to require preoperative bowel preparation and beTable 1
Baseline characteristics.
GDFT (n ¼ 27) Control (n ¼ 54) P value
Age, median [range] 63 [18e86] 61 [27e87] 0.89z
Male 17 (63%) 24 (44%) 0.34
BMI, mean (SD) 27.1 (5.5) 27.8 (6.6) 0.73¶
Preoperative haemoglobin, mean (SD) 130 (17) 127 (19) 0.53¶
ASA score, median [range] 2 [1e3] 2 [1e3] 0.66z
Cr-POSSUM, median [range] 9 [6e18] 10 [6e21] 0.74z
Operation severity, median [range] 7 [7e12] 7 [7e13] 0.85z
Malignancy 25 (93%) 46 (85%) 0.26
Dukes stage 0.56
A 4 (15%) 9 (17%)
B 9 (33%) 10 (19%)
C 11 (41%) 24 (44%)
D 1 (4%) 3 (6%)
Operation
Anterior resection 11 (41%) 29 (54%) 0.35
Abdominoperineal resection 11 (41%) 17 (31%) 0.46
Other 5 (19%) 8 (15%) 0.75
Surgical technique 0.16
Open 27 (100%) 49 (91%)
Laparoscopic 0 (0%) 5 (9%)
Stoma 26 (96%) 52 (96%) 1.00
Bowel preparation 18 (67%) 36 (67%) 1.00
Operation time, mean (SD) 196 (56) 206 (65) 0.52¶
Arterial line 18 (67%) 30 (56%) 0.47
Epidural 19 (70%) 45 (83%) 0.25
ASA, American Society of Anesthesiologists; BMI, body mass index (kg/m2); Cr-
POSSUM, Colorectal Physiological and Operative Severity Score for the enUmera-
tion of Mortality and morbidity; SD, standard deviation. Fisher's exact test used
unless otherwise stated. zManneWhitney U test, ¶t test. GDFT Other: Pan-
proctocolectomy (4); Hartmann's (1); Control Other: Panproctocolectomy (4);
Hartmann's (4).
Complication 1.00
Yes 22 (81%) 44 (81%)
No 5 (19%) 10 (19%)
Complication grade
I 2 (7%) 4 (7%) 1.00
II 15 (56%) 26 (48%) 0.64
III 1 (4%) 4 (7%) 0.66
IV 4 (15%) 2 (4%) 0.09
V 0 (0%) 1 (2%) 1.00
Complication type
Cardiorespiratory 7 (26%) 9 (17%) 0.38
Abdominal collection 4 (15%) 3 (6%) 0.21
Wound infection 1 (4%) 9 (17%) 0.15
Urinary tract infection 2 (7%) 8 (15%) 0.48
Ileus 5 (19%) 6 (11%) 0.49
Haemorrhage 2 (7%) 2 (4%) 0.60
Renal failure 1 (4%) 5 (9%) 0.66
Other 0 (0%) 2 (4%) 0.55
Day of ﬂatus 1 [1e4] 1 [1e6] 0.90z
Discharge day 9 [3e109] 9 [3e32] 0.52z
Readmissions 4 (15%) 11 (20%) 0.76
Total hospital stay 9 [3e109] 10 [3e33] 0.92z
Discharge data and hospital stay are expressed as medians [range]. Fisher's exact
test used unless otherwise stated. zManneWhitney U test.accompanied by the creation of a stoma which poses an additional
metabolic burden. Furthermore, stoma outputs can increase
gastrointestinal losses and may affect postoperative ﬂuid re-
quirements especially in high output states [13]. Therefore, the
published positive ﬁndings in colonic resection and major
abdominal surgery may not be able to be extrapolated to rectal
surgery.
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ﬂuid management protocol [11,20]. In patients undergoing rectal
surgery, postoperative ﬂuid administration may be higher
compared to colonic surgery due to replacement ﬂuid being
required for high stoma outputs or greater awareness of oliguria
due to the urinary catheter being in-situ for longer. These high
volumes of postoperative ﬂuid are not guided by intensive moni-
toring as in the intraoperative phase and may offset any potential
gains from achieving ﬂuid balance in the intraoperative period. This
may be more relevant than in colonic surgery where patients
receive less intravenous ﬂuid postoperatively.
Our institution utilises an Enhanced Recovery protocol for pa-
tients undergoing elective colectomy [21]. This study was also
conducted in an environment of current perioperative practices
such as early feeding, use of epidural analgesia and preoperative
carbohydrate loading. Whilst these elements were not formally
implemented as for the colectomy patients, the results are poten-
tially more applicable to current practice compared to initial trials
which were conducted in the setting of non-optimised periopera-
tive care. Although bowel prep was used, there was no difference in
the proportion of patients receiving it and only one type of prep
(PicoPrep™, Fresenius Kabi, NSW, Australia) was used. It is also
important to note that more recent studies exploring GDFT within
an established enhanced recovery environment have shown
equivalent or inferior outcomes for patients receiving GDFT and
perhaps the previously demonstrated beneﬁts of GDFT have been
offset by improvements in other aspects of perioperative care
[11,22,23]. Moreover, the volume of ﬂuid administered in the con-
trol arm in our study could be regarded as ‘restrictive’ or ‘balanced’
by some deﬁnitions [24] and more recent trials comparing GDFT
and restrictive regimens have not demonstrated a difference be-
tween the two regimens [22,25].
No differences were observed in the total intraoperative ﬂuid
amount administered between the two study arms. Our study
suffers from the limitation of not having a deﬁned protocol for ﬂuid
management in the control arm as in previous studies. Whilst it has
been recognised that commonly available monitoring indices
(heart rate, intraoperative urine output, blood pressure, cyclic
arterial pressure variations) are not sensitive markers of ﬂuid
responsiveness, the exact basis of decision making concerning ﬂuid
administration by individual anaesthetists in this study or others is
unlikely to be as simplistic as a rigid protocol. Thus it is possible
that intraoperative clinical evaluation, combined with information
from other monitoring equipment, led to the patients in the control
groups receiving similar quantities of ﬂuid as the GDFT arm. A high
proportion of patients in the control group also had arterial lines
which would provide information pertinent to ﬂuid management.
Patients in the GDFT arm received more colloid which may be
simply reﬂective of the treatment algorithm. Since the ODM is the
most widely used instrument to conduct GDFT and has been vali-
dated in this context, it is unlikely that erroneous measurements
were obtained. Although interference was observed during the use
of electrosurgical devices, this would not have compromised the
trends in cardiac function observed over 15 min intervals. More-
over, this study has not been conducted in high risk patients alone,
who may beneﬁt from exact titration of intraoperative ﬂuids.
Nonetheless, since recent guidelines have proposed the use of GDFT
for all patients undergoing major abdominal surgery, the lack of
beneﬁt seen in this group of patients has important clinical
implications.
Our study also showed a non-signiﬁcant trend suggesting that
patients managed with GDFT had decreased ﬂuid requirements in
the ﬁrst 24 h after surgery. The absolute volumes of ﬂuid admin-
istered remained lower in the GDFT group for three days post-
operatively but these ﬁndings were less statistically compelling. Apotential reason for this is that even though administered intra-
operative ﬂuid amounts were the same, a greater amount of colloid
ﬂuid in the treatment group may have lead to greater intravascular
volume replacement as recently studied by Yates et al. [26] It is
therefore important to acknowledge that patients in the GDFT
group received more intravascular ﬂuid but any potential
improvement in circulatory support did not translate into
improved clinical outcomes.
The recorded complication rate in this study was higher than
expected. A potential reason for this is meticulous monitoring of
both inpatient and out-of-hospital events. The majority of com-
plications (GDFT: 63%; Control: 55%) wereminor complications and
the major complication rate was consistent with previously pub-
lished studies [24]. Previous meta-analysis of the efﬁcacy of GDFT
had shown a 72% decrease in complications [7]. As a result, the high
complication rate also meant that a 30% reduction in complications
was a clinically signiﬁcant and realistic difference to power the
study for.
It is important to acknowledge that this study is not a rando-
mised trial. The study designwas considered most feasible to avoid
co-intervention bias since our institution was in the process of
increasing its use of laparoscopy and implementing a formal ERAS
program in rectal surgery. Despite the limitations surrounding the
evidence concerning GDFT, it is still supported by a number of
randomised trials. Large phase four studies have also shown im-
provements in clinical outcomes with the use of GDFT [27].
Importantly, however, our study is the only one to be powered
speciﬁcally for total complications in rectal surgery and has not
shown any clinical beneﬁts within a setting of contemporary
perioperative care. Further light on this subject is likely to be shed
by a large randomised trial controlling not only aspects of ﬂuid
management but other aspects of surgical and anaesthetic (e.g.
vasopressors) care. Therefore, the results of this study need to be
conﬁrmed with further procedure-speciﬁc prospective studies
within an environment of optimised perioperative care.
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